Karin Jirström Selected Research

Karin Jirström Research Topics

Disease

163	Neoplasms (Cancer) 08/2022 - 02/2005
93	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2005
38	Adenocarcinoma 01/2022 - 02/2011
27	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 11/2009
16	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2007
15	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 06/2010
14	Melanoma (Melanoma, Malignant) 01/2020 - 07/2011
10	Carcinoma (Carcinomatosis) 02/2022 - 01/2007
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2014
9	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 04/2013
9	Lymphatic Metastasis 02/2022 - 09/2009
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 11/2012
8	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2020 - 11/2010
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 07/2013
7	Lung Neoplasms (Lung Cancer) 01/2020 - 04/2010
7	Ovarian Epithelial Carcinoma 01/2018 - 08/2010
6	Microsatellite Instability 01/2022 - 08/2012
6	Carcinogenesis 01/2021 - 03/2010
6	Disease Progression 07/2015 - 05/2010
6	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 01/2007
5	Stomach Neoplasms (Stomach Cancer) 03/2021 - 12/2014
4	Inflammation (Inflammations) 08/2022 - 01/2015
4	Obesity 01/2019 - 09/2008
3	Hypoxia (Hypoxemia) 01/2020 - 05/2006
3	Adenocarcinoma of Lung 01/2020 - 11/2014
2	Tertiary Lymphoid Structures 01/2020 - 01/2020
2	Body Weight (Weight, Body) 01/2019 - 11/2013

Drug/Important Bio-Agent (IBA)

78	Proteins (Proteins, Gene)FDA Link 02/2022 - 02/2005
49	Biomarkers (Surrogate Marker)IBA 02/2022 - 04/2007
29	Estrogen ReceptorsIBA 01/2022 - 07/2005
24	Tamoxifen FDA LinkGeneric 11/2021 - 01/2005
23	Messenger RNA (mRNA)IBA 02/2022 - 11/2006
16	Hormones (Hormone)IBA 11/2020 - 07/2005
12	Cyclin D1IBA 08/2017 - 09/2005
11	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 07/2005
10	AntibodiesIBA 01/2018 - 10/2008
9	Estrogens (Estrogen)FDA Link 01/2018 - 05/2007
8	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2006
8	ErbB Receptors (EGF Receptor)IBA 01/2020 - 07/2007
8	podocalyxinIBA 01/2020 - 07/2012
7	Small Interfering RNA (siRNA)IBA 02/2022 - 11/2008
7	Biological ProductsIBA 12/2018 - 04/2007
7	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 04/2007
6	Phenobarbital (Luminal)FDA Link 08/2022 - 10/2008
6	Estrogen Receptor alphaIBA 01/2021 - 05/2006
6	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2008
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 09/2008
6	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2015 - 01/2008
5	ParaffinIBA 01/2022 - 07/2011
5	Epidermal Growth Factor (EGF)IBA 03/2021 - 01/2016
5	beta CateninIBA 02/2021 - 08/2012
5	Carrier Proteins (Binding Protein)IBA 01/2021 - 07/2011
5	Thyroid Nuclear Factor 1IBA 01/2019 - 07/2013
4	human ERBB2 proteinIBA 08/2020 - 07/2005
4	Complement Inactivating AgentsIBA 01/2020 - 04/2015
4	Keratin-5 (Keratin 5)IBA 01/2019 - 11/2010
4	LigandsIBA 01/2018 - 11/2013
4	Protein Isoforms (Isoforms)IBA 02/2017 - 04/2010
4	Pharmaceutical PreparationsIBA 01/2017 - 08/2006
4	Glycoproteins (Glycoprotein)IBA 01/2016 - 07/2012
4	CytokinesIBA 10/2015 - 09/2011
4	Tumor Biomarkers (Tumor Markers)IBA 01/2013 - 08/2011
3	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 08/2010
3	Formaldehyde (Formol)FDA Link 01/2022 - 08/2016
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 04/2010
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2010
3	AntigensIBA 01/2020 - 01/2009
3	Oral ContraceptivesIBA 01/2018 - 05/2014
3	Coffee FDA Link 01/2018 - 07/2014
3	ChemokinesIBA 10/2016 - 09/2011
3	ezrinIBA 10/2014 - 01/2007
3	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 04/2014 - 01/2014
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 09/2011 - 12/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2008 - 02/2005
3	Cyclin EIBA 04/2007 - 11/2005
2	Insulin (Novolin)FDA Link 08/2022 - 01/2017
2	Caveolin 1IBA 08/2022 - 01/2020
2	Gemcitabine FDA Link 02/2022 - 01/2016
2	Insulin-Like Growth Factor Binding ProteinsIBA 11/2021 - 01/2021
2	Junctional Adhesion Molecule AIBA 03/2021 - 02/2021
2	TubulinIBA 01/2021 - 05/2012
2	CholesterolIBA 01/2021 - 04/2015
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2021 - 02/2017
2	B7-H1 AntigenIBA 01/2019 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 12/2016
2	Programmed Cell Death 1 ReceptorIBA 01/2019 - 01/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2018 - 01/2017
2	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2018 - 09/2008

Therapy/Procedure

34	Therapeutics 03/2021 - 08/2006
15	Drug Therapy (Chemotherapy) 02/2022 - 06/2011
10	Neoadjuvant Therapy 01/2022 - 08/2011
10	Radiotherapy 01/2021 - 08/2011
7	Adjuvant Chemotherapy 01/2022 - 09/2009
6	Pancreaticoduodenectomy 01/2018 - 01/2014
5	Immunotherapy 11/2020 - 01/2020
5	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018 - 05/2007
3	Prostatectomy (Retropubic Prostatectomy) 04/2013 - 05/2010
2	Cystectomy 02/2022 - 01/2019
2	Chemoradiotherapy 01/2019 - 09/2017
2	Segmental Mastectomy (Lumpectomy) 12/2018 - 11/2014